Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory

December 18, 2023

https://www.globenewswire.com/news-release/2023/12/18/2797871/0/en/Neuronetics-Receives-510-k-Clearance-for-NeuroSite-Coil-Placement-Accessory.html

MALVERN, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the U.S. Food and Drug Administration 510(k) clearance of NeuroSite™ Coil Placement Accessory, a state-of-the-art tool that simplifies measurement and coil positioning during NeuroStar transcranial magnetic stimulation (TMS) treatments. This proprietary accessory, designed with versatility and provider convenience in mind, seamlessly integrates with both legacy and new NeuroStar systems and further enhances efficiency and patient experience.

Read more at globenewswire.com

Related news for (STIM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.